Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
종목 코드 EKSO
회사 이름Ekso Bionics Holdings Inc
상장일Apr 10, 2013
CEOMr. Scott G. Davis
직원 수61
유형Ordinary Share
회계 연도 종료Apr 10
주소101 Glacier Point
도시SAN RAFAEL
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호94901
전화15109841761
웹사이트https://eksobionics.com/
종목 코드 EKSO
상장일Apr 10, 2013
CEOMr. Scott G. Davis
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음